Sipple syndrome is also known as:-
**Core Concept**
Sipple syndrome is a rare genetic disorder characterized by the occurrence of multiple endocrine neoplasia type 2A (MEN2A), which involves the development of medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism. It is caused by mutations in the RET proto-oncogene.
**Why the Correct Answer is Right**
The correct answer is related to the genetic basis of Sipple syndrome. The RET proto-oncogene is a tyrosine kinase receptor that plays a crucial role in the development and function of various tissues, including the thyroid, adrenal glands, and parathyroid glands. Mutations in the RET gene lead to the constitutive activation of the tyrosine kinase domain, resulting in the uncontrolled growth and proliferation of cells in these tissues, ultimately leading to the development of tumors.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the genetic basis of Sipple syndrome. While pheochromocytoma is a component of MEN2A, it is not the primary genetic association.
**Option B:** This option is incorrect because it misrepresents the genetic cause of Sipple syndrome. MEN1 is a different syndrome that involves the development of tumors in the parathyroid glands, pancreas, and pituitary gland, and is caused by mutations in the MEN1 gene.
**Option C:** This option is incorrect because it does not accurately describe the genetic basis of Sipple syndrome. While hyperparathyroidism is a component of MEN2A, it is not the primary genetic association.
**Clinical Pearl / High-Yield Fact**
Sipple syndrome is a classic example of a genetic disorder that involves the development of multiple endocrine neoplasias. It highlights the importance of genetic testing in the diagnosis and management of patients with endocrine tumors.
**Correct Answer: A. Multiple endocrine neoplasia type 2A (MEN2A)**